Researchers from the University of Bern analyzed over 300,000 FDA reports and found semaglutide use was linked to a higher ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

People taking a popular diabetes medication called semaglutide, sold under brand names like Ozempic, Wegovy, and Rybelsus may ...

The researchers tracked nearly 175,000 patients with diabetes who received semaglutide ... The higher risk of developing the sight-threatening eye problem known as nonarteritic anterior ischemic ...

open image in gallery Semaglutide - the active ingredient in Ozempic and other Novo products - has been linked to eye conditions (Getty/iStock) In subgroup analyses, the elevated risk for NAION ...

Parker Waichman LLP, a nationally recognized law firm dedicated to representing victims of defective drugs and devices, recently filed a lawsuit against Novo Nordisk on behalf of a New Jersey based ...

Its diversified portfolio in men's and women's health ... that risk played out for the company as the FDA crackdown threat materialized regarding the compounding of GLP-1 semaglutide, a version ...

The list of “biohacks” is extensive and includes extreme diets, supplement use, juicing, red light therapy, cold exposure in ...

Eye health: If you have a history ... This is because semaglutide, the active ingredient in Ozempic may increase your risk of kidney injury. How long does it take Ozempic to get out of your ...

I am concerned the mad scramble to get hold of weight-loss jabs has led to a Wild West market, where it's easy to buy these ...